Novartis improves its 2024 outlook for the third time with Cosentyx
Swiss drugmaker Novartis on Tuesday raised its 2024 profit forecast for the third time amid greater use of its prescription drugs such as psoriasis and arthritis drug Cosentyx.
ПОПУЛЯРНЫЕ ПОСТЫ
Putin may discuss Ukraine peace deal with Trump
Ноябрь 22, 2024
Spain’s vice-president Ribera blames floods on climate change
Ноябрь 22, 2024
Storm lashes northwestern US, killing two people
Ноябрь 22, 2024
Iceland volcano erupts for tenth time in three years
Ноябрь 22, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ